<DOC>
	<DOCNO>NCT01623271</DOCNO>
	<brief_summary>The purpose study see FDA-approved drug ( Gralise ) help people certain type neuropathic pain without cause many side effect .</brief_summary>
	<brief_title>Treatment Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin ( Gralise )</brief_title>
	<detailed_description>This research conduct see drug Gralise help people Complex Regional Pain Syndrom Type I ( CRPS I ) without cause many side effect . CRPS I one common condition neuropathic pain ( pain result damage nerves peripheral nervous system ) . Gralise approve U.S. Food Drug Administration ( FDA ) treat postherpetic neuralgia ( complication disease Shingles , cause chickenpox virus ) , approve treat CRPS I .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Complex Regional Pain Syndromes</mesh_term>
	<mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>1 . Subject 18 80 year age . 2 . Subject Gralise . 3 . Subject gabapentin least one month . 4 . Subject agrees make change his/her current pain medication study period ensure comparison make Gralise treatment . 5 . Subject VAS pain score 5 begin study . 6 . Subject CRPS I least three month avoid clinical uncertainty minimize study variation . 7 . Female subject childbearing age must negative urine pregnancy test initial visit . 1 . Subject severe liver renal disease affect elimination Gralise . ( Renal dysfunction define eGFR &lt; 60 . Hepatic dysfunction define LFTs â‰¥ 3X ULN . ) 2 . Subject pending litigation relate his/her CRPS I condition . 3 . Subject pregnant lactating . 4 . Subject allergic gabapentin Gralise . 5 . Subject positive urine ( illicit ) drug test . 6 . Subject history suicidal thought behavior , self report documented medical history . 7 . Subjects know seizure disorder ( except febrile seizure ) and/or take antiepileptic drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>CRPS I</keyword>
</DOC>